Franz-Werner Dippel Selected Research

Isophane Insulin (NPH Insulin)

10/2015	Treatment persistence after initiating basal insulin in type 2 diabetes patients: A primary care database analysis.
5/2015	Early discontinuation and related treatment costs after initiation of Basal insulin in type 2 diabetes patients: a German primary care database analysis.
5/2013	Resource consumption and costs of treatment in patients with type 1 diabetes under intensified conventional therapy under German real-life conditions.
1/2012	Health economic evaluation of insulin glargine vs NPH insulin in intensified conventional therapy for type 1 diabetes in Germany.
10/2011	Health economic evaluations comparing insulin glargine with NPH insulin in patients with type 1 diabetes: a systematic review.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Franz-Werner Dippel Research Topics

Disease

8	Type 2 Diabetes Mellitus (MODY) 10/2015 - 01/2008
3	Muscular Diseases (Myopathy) 01/2018 - 01/2018
3	Hypercholesterolemia 01/2018 - 06/2017
3	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 05/2013 - 10/2011
2	Hypoglycemia (Reactive Hypoglycemia) 05/2013 - 01/2012
1	Hyperlipoproteinemia Type II (Familial Hypercholesterolemia) 01/2018
1	Cardiovascular Diseases (Cardiovascular Disease) 01/2018
1	Coronary Disease (Coronary Heart Disease) 01/2018
1	Diabetes Mellitus 01/2018
1	Acute Coronary Syndrome 01/2018
1	Ischemic Stroke 01/2018
1	Peripheral Arterial Disease 01/2018
1	Heart Failure 10/2015
1	Diabetes Complications 10/2012
1	Diabetic Foot 10/2012
1	Infarction (Infarctions) 01/2012
1	Stroke (Strokes) 01/2012

Drug/Important Bio-Agent (IBA)

8	Insulin Glargine (Lantus)FDA Link 10/2015 - 01/2008
6	Insulin (Novolin)FDA Link 10/2015 - 01/2008
5	Isophane Insulin (NPH Insulin)FDA Link 10/2015 - 10/2011
3	oxidized low density lipoproteinIBA 01/2018 - 06/2017
3	Hypoglycemic Agents (Hypoglycemics)IBA 10/2015 - 06/2009
2	Protamines (Protamine Sulfate)FDA Link 01/2012 - 01/2008
1	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2018
1	LipidsIBA 06/2017
1	LDL CholesterolIBA 06/2017
1	Metformin (Glucophage)FDA LinkGeneric 10/2015
1	InsulinsIBA 05/2013
1	Glucose (Dextrose)FDA LinkGeneric 05/2013
1	Long-Acting Insulin (Insulin, Long Acting)FDA Link 01/2012
1	Blood Glucose (Blood Sugar)IBA 01/2012
1	Insulin Detemir (Levemir)FDA Link 08/2010
1	Insulin Aspart (NovoLog)FDA Link 08/2010
1	Insulin Lispro (Humalog)FDA Link 06/2009
1	neutral insulin FDA Link 01/2008

Therapy/Procedure

9	Therapeutics 01/2018 - 01/2008
2	Blood Component Removal (Apheresis) 01/2018 - 01/2018
1	Drug Therapy (Chemotherapy) 01/2018
1	Adjuvant Chemotherapy 01/2018
1	Surgical Amputation (Amputations) 10/2012
1	Glycemic Control 01/2012